Study of OT-551 Eye Drops to Prevent or Delay Progression of Nuclear Cataracts Following Vitreous Removal
Status:
Terminated
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to compare the ability of two doses of OT-551 ophthalmic
solution and drug-free solution to safely and effectively prevent or delay the progression of
nuclear cataracts that frequently develop as a result of vitrectomy (surgery for retina
repair), thereby avoiding the need for a second surgery (cataract removal). Victrectomies
involve removal of the jelly-like substance (vitreous) that is located in a cavity behind the
lens.